Bora CDMO Bora CDMO

X

Find Cantrixil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Cantrixil
Also known as: 5dvs457heg, Trx-e-002-1, (+)-cis-4-(para-hydroxyphenyl)-7,4-dihydroxy-3,5-dimethoxy-8-methylisoflavan, 1803036-93-2, Unii-5dvs457heg, Schembl19410294
Molecular Formula
C24H24O6
Molecular Weight
408.4  g/mol
InChI Key
JFVVPUGGRUGRBJ-AVRDEDQJSA-N
FDA UNII
5DVS457HEG

Cantrixil is a cyclodextrin-encapsulated, third generation super-benzopyran (SBP) compound with potential antineoplastic activity. Upon intraperitoneal (IP) administration, cantrixil enhances the activation and expression of c-Jun, downregulates phosphorylated extracellular signal-regulated kinase (p-ERK) and induces activation of caspase-3, -7 and -9, thereby inducing tumor cell apoptosis. c-Jun, an activator protein-1 (AP-1) transcription factor component, is involved in a wide range of cellular processes including cell cycle progression, differentiation, cell transformation and apoptosis.
1 2D Structure

Cantrixil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,4S)-3-(4-hydroxy-3,5-dimethoxyphenyl)-4-(4-hydroxyphenyl)-8-methyl-3,4-dihydro-2H-chromen-7-ol
2.1.2 InChI
InChI=1S/C24H24O6/c1-13-19(26)9-8-17-22(14-4-6-16(25)7-5-14)18(12-30-24(13)17)15-10-20(28-2)23(27)21(11-15)29-3/h4-11,18,22,25-27H,12H2,1-3H3/t18-,22-/m0/s1
2.1.3 InChI Key
JFVVPUGGRUGRBJ-AVRDEDQJSA-N
2.1.4 Canonical SMILES
CC1=C(C=CC2=C1OCC(C2C3=CC=C(C=C3)O)C4=CC(=C(C(=C4)OC)O)OC)O
2.1.5 Isomeric SMILES
CC1=C(C=CC2=C1OC[C@H]([C@H]2C3=CC=C(C=C3)O)C4=CC(=C(C(=C4)OC)O)OC)O
2.2 Other Identifiers
2.2.1 UNII
5DVS457HEG
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-(para-hydroxyphenyl)-7,4'-dihydroxy-3',5'-dimethoxy-8-methylisoflavan

2. Trx-e-002-1

2.3.2 Depositor-Supplied Synonyms

1. 5dvs457heg

2. Trx-e-002-1

3. (+)-cis-4-(para-hydroxyphenyl)-7,4-dihydroxy-3,5-dimethoxy-8-methylisoflavan

4. 1803036-93-2

5. Unii-5dvs457heg

6. Schembl19410294

7. Hy-114250

8. Cs-0080663

9. Cis-4-(p-hydroxyphenyl)-7,4'-dihydroxy-3',5'-dimethoxy-8-methylisoflavan

2.4 Create Date
2017-09-13
3 Chemical and Physical Properties
Molecular Weight 408.4 g/mol
Molecular Formula C24H24O6
XLogP34.4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass408.15728848 g/mol
Monoisotopic Mass408.15728848 g/mol
Topological Polar Surface Area88.4 Ų
Heavy Atom Count30
Formal Charge0
Complexity536
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY